author_facet Simonin, Yannick
Charron, Yves
Sonderegger, Peter
Vassalli, Jean-Dominique
Kato, Ann C.
Simonin, Yannick
Charron, Yves
Sonderegger, Peter
Vassalli, Jean-Dominique
Kato, Ann C.
author Simonin, Yannick
Charron, Yves
Sonderegger, Peter
Vassalli, Jean-Dominique
Kato, Ann C.
spellingShingle Simonin, Yannick
Charron, Yves
Sonderegger, Peter
Vassalli, Jean-Dominique
Kato, Ann C.
The Journal of Neuroscience
An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease
General Neuroscience
author_sort simonin, yannick
spelling Simonin, Yannick Charron, Yves Sonderegger, Peter Vassalli, Jean-Dominique Kato, Ann C. 0270-6474 1529-2401 Society for Neuroscience General Neuroscience http://dx.doi.org/10.1523/jneurosci.3582-06.2006 <jats:p>Various studies suggest that proteolytic activity may be involved in a number of neurodegenerative disorders, including stroke and seizure. In this report, we examined the role of tryptic serine proteases, plasminogen activators (PAs), in the evolution of a neurodegenerative disease. Transgenic mice overexpressing an axonally secreted inhibitor of serine proteases (neuroserpin) were crossed with mice characterized by a “dying-back” motor neuron disease [progressive motor neuronopathy (<jats:italic>pmn/pmn</jats:italic>)]. Compared with<jats:italic>pmn/pmn</jats:italic>mice that showed an increase in PA activity, double mutant mice had decreased PA activity in sciatic nerves and spinal cord; their lifespan was increased by 50%, their motor behavior was stabilized, and histological analysis revealed increased numbers of myelinated axons and rescue of motoneuron number and size. This is the first report showing that a class of serine proteases (PAs) may be involved in the pathogenesis of a motor neuron disease and more specifically in axonal degeneration. Inhibiting serine proteases could offer a new strategy for delaying these disorders.</jats:p> An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease The Journal of Neuroscience
doi_str_mv 10.1523/jneurosci.3582-06.2006
facet_avail Online
Free
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTUyMy9qbmV1cm9zY2kuMzU4Mi0wNi4yMDA2
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTUyMy9qbmV1cm9zY2kuMzU4Mi0wNi4yMDA2
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint Society for Neuroscience, 2006
imprint_str_mv Society for Neuroscience, 2006
issn 0270-6474
1529-2401
issn_str_mv 0270-6474
1529-2401
language English
mega_collection Society for Neuroscience (CrossRef)
match_str simonin2006aninhibitorofserineproteasesneuroserpinactsasaneuroprotectiveagentinamousemodelofneurodegenerativedisease
publishDateSort 2006
publisher Society for Neuroscience
recordtype ai
record_format ai
series The Journal of Neuroscience
source_id 49
title An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease
title_unstemmed An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease
title_full An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease
title_fullStr An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease
title_full_unstemmed An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease
title_short An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease
title_sort an inhibitor of serine proteases, neuroserpin, acts as a neuroprotective agent in a mouse model of neurodegenerative disease
topic General Neuroscience
url http://dx.doi.org/10.1523/jneurosci.3582-06.2006
publishDate 2006
physical 10614-10619
description <jats:p>Various studies suggest that proteolytic activity may be involved in a number of neurodegenerative disorders, including stroke and seizure. In this report, we examined the role of tryptic serine proteases, plasminogen activators (PAs), in the evolution of a neurodegenerative disease. Transgenic mice overexpressing an axonally secreted inhibitor of serine proteases (neuroserpin) were crossed with mice characterized by a “dying-back” motor neuron disease [progressive motor neuronopathy (<jats:italic>pmn/pmn</jats:italic>)]. Compared with<jats:italic>pmn/pmn</jats:italic>mice that showed an increase in PA activity, double mutant mice had decreased PA activity in sciatic nerves and spinal cord; their lifespan was increased by 50%, their motor behavior was stabilized, and histological analysis revealed increased numbers of myelinated axons and rescue of motoneuron number and size. This is the first report showing that a class of serine proteases (PAs) may be involved in the pathogenesis of a motor neuron disease and more specifically in axonal degeneration. Inhibiting serine proteases could offer a new strategy for delaying these disorders.</jats:p>
container_issue 41
container_start_page 10614
container_title The Journal of Neuroscience
container_volume 26
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792340286946410503
geogr_code not assigned
last_indexed 2024-03-01T16:01:37.072Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=An+Inhibitor+of+Serine+Proteases%2C+Neuroserpin%2C+Acts+as+a+Neuroprotective+Agent+in+a+Mouse+Model+of+Neurodegenerative+Disease&rft.date=2006-10-11&genre=article&issn=1529-2401&volume=26&issue=41&spage=10614&epage=10619&pages=10614-10619&jtitle=The+Journal+of+Neuroscience&atitle=An+Inhibitor+of+Serine+Proteases%2C+Neuroserpin%2C+Acts+as+a+Neuroprotective+Agent+in+a+Mouse+Model+of+Neurodegenerative+Disease&aulast=Kato&aufirst=Ann+C.&rft_id=info%3Adoi%2F10.1523%2Fjneurosci.3582-06.2006&rft.language%5B0%5D=eng
SOLR
_version_ 1792340286946410503
author Simonin, Yannick, Charron, Yves, Sonderegger, Peter, Vassalli, Jean-Dominique, Kato, Ann C.
author_facet Simonin, Yannick, Charron, Yves, Sonderegger, Peter, Vassalli, Jean-Dominique, Kato, Ann C., Simonin, Yannick, Charron, Yves, Sonderegger, Peter, Vassalli, Jean-Dominique, Kato, Ann C.
author_sort simonin, yannick
container_issue 41
container_start_page 10614
container_title The Journal of Neuroscience
container_volume 26
description <jats:p>Various studies suggest that proteolytic activity may be involved in a number of neurodegenerative disorders, including stroke and seizure. In this report, we examined the role of tryptic serine proteases, plasminogen activators (PAs), in the evolution of a neurodegenerative disease. Transgenic mice overexpressing an axonally secreted inhibitor of serine proteases (neuroserpin) were crossed with mice characterized by a “dying-back” motor neuron disease [progressive motor neuronopathy (<jats:italic>pmn/pmn</jats:italic>)]. Compared with<jats:italic>pmn/pmn</jats:italic>mice that showed an increase in PA activity, double mutant mice had decreased PA activity in sciatic nerves and spinal cord; their lifespan was increased by 50%, their motor behavior was stabilized, and histological analysis revealed increased numbers of myelinated axons and rescue of motoneuron number and size. This is the first report showing that a class of serine proteases (PAs) may be involved in the pathogenesis of a motor neuron disease and more specifically in axonal degeneration. Inhibiting serine proteases could offer a new strategy for delaying these disorders.</jats:p>
doi_str_mv 10.1523/jneurosci.3582-06.2006
facet_avail Online, Free
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTUyMy9qbmV1cm9zY2kuMzU4Mi0wNi4yMDA2
imprint Society for Neuroscience, 2006
imprint_str_mv Society for Neuroscience, 2006
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 0270-6474, 1529-2401
issn_str_mv 0270-6474, 1529-2401
language English
last_indexed 2024-03-01T16:01:37.072Z
match_str simonin2006aninhibitorofserineproteasesneuroserpinactsasaneuroprotectiveagentinamousemodelofneurodegenerativedisease
mega_collection Society for Neuroscience (CrossRef)
physical 10614-10619
publishDate 2006
publishDateSort 2006
publisher Society for Neuroscience
record_format ai
recordtype ai
series The Journal of Neuroscience
source_id 49
spelling Simonin, Yannick Charron, Yves Sonderegger, Peter Vassalli, Jean-Dominique Kato, Ann C. 0270-6474 1529-2401 Society for Neuroscience General Neuroscience http://dx.doi.org/10.1523/jneurosci.3582-06.2006 <jats:p>Various studies suggest that proteolytic activity may be involved in a number of neurodegenerative disorders, including stroke and seizure. In this report, we examined the role of tryptic serine proteases, plasminogen activators (PAs), in the evolution of a neurodegenerative disease. Transgenic mice overexpressing an axonally secreted inhibitor of serine proteases (neuroserpin) were crossed with mice characterized by a “dying-back” motor neuron disease [progressive motor neuronopathy (<jats:italic>pmn/pmn</jats:italic>)]. Compared with<jats:italic>pmn/pmn</jats:italic>mice that showed an increase in PA activity, double mutant mice had decreased PA activity in sciatic nerves and spinal cord; their lifespan was increased by 50%, their motor behavior was stabilized, and histological analysis revealed increased numbers of myelinated axons and rescue of motoneuron number and size. This is the first report showing that a class of serine proteases (PAs) may be involved in the pathogenesis of a motor neuron disease and more specifically in axonal degeneration. Inhibiting serine proteases could offer a new strategy for delaying these disorders.</jats:p> An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease The Journal of Neuroscience
spellingShingle Simonin, Yannick, Charron, Yves, Sonderegger, Peter, Vassalli, Jean-Dominique, Kato, Ann C., The Journal of Neuroscience, An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease, General Neuroscience
title An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease
title_full An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease
title_fullStr An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease
title_full_unstemmed An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease
title_short An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease
title_sort an inhibitor of serine proteases, neuroserpin, acts as a neuroprotective agent in a mouse model of neurodegenerative disease
title_unstemmed An Inhibitor of Serine Proteases, Neuroserpin, Acts as a Neuroprotective Agent in a Mouse Model of Neurodegenerative Disease
topic General Neuroscience
url http://dx.doi.org/10.1523/jneurosci.3582-06.2006